This Week’s Biotech Highlights
Everybody wants their 15 minutes of fame, and this week there was plenty of recognition to go around — both in the biotech community and in the legal community.
The FDA, famous for restrictive rules on communications, is having a hard time adjusting to current internet trends, leading to some controversial decisions about Google search ads. Trying to do better, FDA held a two-day hearing about the use of the internet and social media for online drug marketing so it can calibrate its decisions for a new era. Rule-making will follow at the old era pace, though.
Simon Fodden . . . [more]
